- to know the unique genetic composition of each patient
- sometimes to diagnose cancers(in selected cases)
- to decide when to stop (whether further treatment required)
- decide if gentler treatment approach will be feasible or not
- when all other treatment approaches have exhausted
Real life situation
- A 68-year-old patient with lung cancer avoided hospital admission thanks to a targeted tablet, allowing continued daily routines and family life.
- A teenager with a rare mutation received a therapy designed for her specific genetic profile leading to remission after conventional drugs failed.
- Middle-aged parents managed both cancer and diabetes with a personalized regimen, reducing serious side effect risk and supporting family responsibilities.